WUXI PHARMATECH EXPANDS NEW MATERIALS CHARACTERISATION FACILITY

摘要

WuXi PharmaTech, a leading pharma, biotech and medical device R&D services company with operations in China and the US, has completed an expansion of its materials characterisation testing facility in St Paul, Minnesota. A new 20,000ft~2 laboratory will offer expanded capacity for existing services like particle identification and extractable/leachable testing, and add a new service - dynamic light scattering for nanoparticle characterisation. These services are required by the FDA for filings of medical devices or biologies.The expansion is designed on a flexible floor plan that allows rapid scale-up of technologies to increase capacities for chemical analysis of medical materials. The expanded laboratory will begin operation by the end of this month.